Synergy of human neutrophils with fluconazole in killing Candida species
- PMID: 8981777
- DOI: 10.1007/BF00436717
Synergy of human neutrophils with fluconazole in killing Candida species
Abstract
The killing of Candida species by human neutrophils in a long-term 24-h assay and possible synergy with fluconazole (FCZ) for killing was investigated. The test medium (TM) consisted of RPMI-1640, penicillin and streptomycin (P/S), and 10% fresh autologous serum. TM alone was highly fungistatic for Candida species compared to TM without serum. When neutrophils were cocultured in TM with Candida species for 24 h the inoculum colony-forming units (CFU) were always significantly reduced (killing) by 58 to 99%. FCZ was tested over a range of 1-500 micrograms/ml, and though almost always fungistatic itself, it synergized with neutrophils for significantly increased killing of C. albicans (isolate Sh27) (P < 0.01) and C. albicans (isolate 94-20) (P < 0.05). Killing of non-albicans Candida species was so efficient in the absence of FCZ that demonstration of synergy with FCZ was difficult.
Similar articles
-
Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.Mycopathologia. 1995-1996;132(3):123-8. doi: 10.1007/BF01103976. Mycopathologia. 1995. PMID: 8684425
-
Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species.J Infect Dis. 1995 Dec;172(6):1620-3. doi: 10.1093/infdis/172.6.1620. J Infect Dis. 1995. PMID: 7594731
-
Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.J Med Microbiol. 1998 Apr;47(4):359-63. doi: 10.1099/00222615-47-4-359. J Med Microbiol. 1998. PMID: 9569003
-
Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.Antimicrob Agents Chemother. 1998 Apr;42(4):907-10. doi: 10.1128/AAC.42.4.907. Antimicrob Agents Chemother. 1998. PMID: 9559806 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.Mycopathologia. 2001;152(1):5-13. doi: 10.1023/a:1011900630987. Mycopathologia. 2001. PMID: 11694096 Review.
-
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis.Front Microbiol. 2019 Jul 11;10:1469. doi: 10.3389/fmicb.2019.01469. eCollection 2019. Front Microbiol. 2019. PMID: 31354640 Free PMC article.
-
Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.Antimicrob Agents Chemother. 1997 Jul;41(7):1575-8. doi: 10.1128/AAC.41.7.1575. Antimicrob Agents Chemother. 1997. PMID: 9210688 Free PMC article.
-
Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.Antimicrob Agents Chemother. 1998 Sep;42(9):2299-303. doi: 10.1128/AAC.42.9.2299. Antimicrob Agents Chemother. 1998. PMID: 9736553 Free PMC article.
-
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.Antimicrob Agents Chemother. 1999 Nov;43(11):2635-41. doi: 10.1128/AAC.43.11.2635. Antimicrob Agents Chemother. 1999. PMID: 10543740 Free PMC article.